Discontinuation report 5% DEXTROSE AND 0.9% SODIUM CHLORIDE
Report ID | 148677 |
Drug Identification Number | 00038946 |
Brand name | 5% DEXTROSE AND 0.9% SODIUM CHLORIDE |
Common or Proper name | Dextrose and Sodium Chloride Injection USP |
Company Name | ICU MEDICAL CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM CHLORIDE DEXTROSE |
Strength(s) | 9MG 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 500 mL |
ATC code | B05BB |
ATC description | I.V. SOLUTIONS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2022-09-01 |
Actual discontinuation date | 2022-11-30 |
Remaining supply date | 2022-09-01 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-12-15 | French | Compare |
v3 | 2022-12-15 | English | Compare |
v2 | 2021-11-02 | French | Compare |
v1 | 2021-11-02 | English | Compare |
Showing 1 to 4 of 4